-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The post-discharge outcome of cancer patients undergoing percutaneous coronary intervention (PCI) is not yet clear.
Recently, the medsci.
medsci.
Between 2010 and 2014, researchers included patients who received PCI in the US admissions database to evaluate the impact of cancer on AMI and bleeding after 90-day hospitalization.
A total of 1,933,324 patients were included in the study (2.
Breast cancer colon cancer
It can be seen that after PCI, cancer patients are at increased risk of re-admission due to AMI or bleeding.
After PCI, cancer patients are at increased risk of re-admission due to AMI or bleeding.
Original source:
Chun Shing Kwok,et al.
org/10.
1093/eurheartj/ehaa1032" target="_blank" rel="noopener">Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA in this message